Disc Medicine (NASDAQ: IRON) net income
Disc Medicine reported a net loss of $212.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $109.4m. Earnings per share were −$6.01.
Disc Medicine's best year of the last 6 was fiscal 2021. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$212.2m | — | — | −$6.01 |
| 2024 | −$109.4m | — | — | −$3.96 |
| 2023 | −$76.4m | — | — | −$3.42 |
| 2022 | −$46.8m | — | — | −$45.05 |
| 2021 | −$36.0m | — | — | −$40.95 |
| 2020 | −$40.8m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Disc Medicine net income compared with its sector
By net income for its latest fiscal year, Disc Medicine ranks 418th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 416th | Verastem | −$209.5m | −677.6% |
| 417th | Damora Therapeutics | −$209.8m | — |
| 418th | Disc Medicine | −$212.2m | — |
| 419th | Immunome | −$212.4m | −3,060.0% |
| 420th | Cullinan Therapeutics | −$219.9m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Disc Medicine
- How much did Disc Medicine earn in fiscal 2025?
- Disc Medicine reported a net loss of $212.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $109.4m.
- What are the earnings per share of Disc Medicine?
- They were −$6.01 in fiscal 2025, compared with −$3.96 in fiscal 2024.
- Where does Disc Medicine rank in its sector by net income?
- It ranks 418th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Disc Medicine come from?
- From the annual report (Form 10-K) that Disc Medicine files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Disc Medicine files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Disc Medicine: the Disc Medicine page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.